Kaercher, T., Hanisch, F., Stapelkamp, R., & Guthoff, R. (2014). Safety and efficacy of a preservative‐free, hyaluronic acid–based tear substitute in patients with dry eye syndrome: A multicenter, open‐label study. Clinical Ophthalmology, 8, 397–404.
Craig, J. P., Nichols, K. K., Akpek, E. K., Caffery, B., Dua, H. S., Joo, C. K., … Stapleton, F. (2017). TFOS DEWS II Definition and Classification Report. The Ocular Surface, 15(3), 276–283. https://doi.org/10.1016/j.jtos.2017.05.008
Georgiev, Georgi A. et al. “Surface chemistry study of the interactions of benzalkonium chloride with films of meibum, corneal cells lipids, and whole tears.” Investigative Ophthalmology & Visual Science vol. 52, 7: 4645–54. 28 Jun. 2011. doi:10.1167/iovs.10-6271.
Liu, Xing et al. “Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications.” Chinese Medical Journal vol. 128, 18 (2015): 2444–49. doi:10.4103/0366-6999.164927
Pauloin, Thierry et al. “In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride.” European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences vol. 34, 4–5 (2008): 263–73. doi:10.1016/j.ejps.2008.04.006
Wu Han et al. “Genoprotective effect of hyaluronic acid against benzalkonium chloride–induced DNA damage in human corneal epithelial cells.” Molecular Vision vol. 17 (2011): 3364–70.
Holly, F. J. “Surface chemical evaluation of artificial tears and their ingredients, II: interaction with a superficial lipid layer.” Contact Lens 1978; 4: 52–65.
Zhao, J. & Wollmer, P. “Air pollutants and tear film stability: a method for experimental evaluation.” Clinical Physiology 2000; 121: 282–286.
Wilson, W. S., Duncan, A. J. & Jay, J. L. “Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man.” British Journal of Ophthalmology 1975; 59: 667–69.
Ishibashi, T., Yokoi, N. & Kinoshita, S. “Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride.” Journal of Glaucoma 2003; 12: 486–90.
Pauloin, Thierry; Dutot, Mélody; Joly, Francine; Warnet, Jean-Michel; Rat, Patrice. “High Molecular Weight Hyaluronan Decreases UVB-Induced Apoptosis and Inflammation in Human Epithelial Corneal Cells.” Molecular Vision 2009;15:777–83. PMID:19325714; PMCID:PMC2660376.
Pattmöller, M.¹; Szentmáry, N.¹ ²; Eppig, T.³; Groß, D.⁴; Seitz, B.¹. “Safety of Hyaluronic Acid in Postoperative Treatment after Penetrating Keratoplasty.” October 2016.
Müller-Lierheim, W. G. K. “Why Chain Length of Hyaluronan in Eye Drops Matters.” Diagnostics (Basel), vol. 10, no. 8, 23 July 2020, article 511. doi:10.3390/diagnostics10080511.
Monslow, J.; Govindaraju, P.; Puré, E. “Hyaluronan – A Functional and Structural Sweet Spot in the Tissue Microenvironment.” Frontiers in Immunology, 15 May 2015, vol. 6, article 231. doi:10.3389/fimmu.2015.00231.
Jain, Sparshi¹*; Singh, Sweta²; Nagar, Anjali³. “Brief Communication: Dexpanthenol and Its Ophthalmic Uses—Impact of Hyaluronic Acid, Panthenol and Its Combination on Epithelial Wound Healing in Murine Corneas.”
Bünger, J., & Driller, H. (2004). Ectoin: An effective natural substance to prevent UVA-induced premature photoaging. Skin Pharmacology and Physiology, 17(5), 232–237. https://doi.org/10.1159/000080216
Hyaluronic Acid in Inflammation and Tissue Regeneration – Malgorzata Litwiniuk, MD; Alicia Kreiner; and Tomasz Grzela, PhD. Wounds 2016; 28(3): 78–88.
Graf, R., Anzali, S., Bünger, J., Pflücker, F., & Driller, H. (2008). The multifunctional role of ectoine as a natural cell protectant. Clinical Dermatology, 26(4), 326–333. https://doi.org/10.1016/j.clindermatol.2008.01.002
Werkhäuser, N., Bilstein, A., & Sonnemann, U. (2014). Treatment of allergic rhinitis with ectoine-containing nasal spray and eye drops in comparison with azelastine-containing or cromoglycic acid-containing formulations. Journal of Allergy, 2014, Article 176597. https://doi.org/10.1155/2014/176597
Harishchandra, R. K., Wulff, S., Lentzen, G., Neuhaus, T., & Galla, H. J. (2010). The effect of compatible solute ectoine on the structural organization of lipid monolayer and bilayer membranes. Biophysical Chemistry, 150(1–3), 37–46. https://doi.org/10.1016/j.bpc.2010.02.007
Dwivedi, M., Backers, H., Harishchandra, R. K., & Galla, H. J. (2014). Biophysical investigations of the structure and function of the tear fluid lipid layer and the effect of ectoine. Part A: Natural meibomian lipid films. Biochimica et Biophysica Acta (BBA) – Biomembranes, 1838(10), 2708–2715. https://doi.org/10.1016/j.bbamem.2014.05.011
van Setten, G.-B., Stachs, O., Dupas, B., Turhan, S. A., Seitz, B., Reitsamer, H., Winter, K., Horwath-Winter, J., Guthoff, R. F., & Müller-Lierheim, W. G. K. (2020). The HYLAN M study: Efficacy of 0.15% high molecular weight hyaluronan fluid in the treatment of severe dry eye disease in a multicenter randomized trial. Journal of Clinical Medicine, 9(11), 3536. https://doi.org/10.3390/jcm9113536 (pubmed.ncbi.nlm.nih.gov)
Medic, N., Boldin, I., Berisha, B., Matijak-Kronschachner, B., Aminfar, H., Schwantzer, G., Müller-Lierheim, W. G. K., van Setten, G.-B., & Horwath-Winter, J. (2024). Application frequency – key indicator for the efficiency of severe dry eye disease treatment – evidence for the importance of molecular weight of hyaluronan in lubricating agents. Acta Ophthalmologica, 102(5), e663–e671. https://doi.org/10.1111/aos.16609 (pubmed.ncbi.nlm.nih.gov)
Pattmöller M, Szentmáry N, Eppig T, Groß D, Seitz B. Verträglichkeit von Hyaluronsäure zur Oberflächenpflege nach perforierender Keratoplastik [Safety of Hyaluronic Acid in Postoperative Treatment after Penetrating Keratoplasty]. Klin Monbl Augenheilkd. 2018 Jan;235(1):64-72. German. doi: 10.1055/s-0042-116158. Epub 2016 Oct 6. PMID: 27711953.
Kojima, T., Nagata, T., Kudo, H., Müller-Lierheim, W. G. K., van Setten, G. B., Dogru, M., & Tsubota, K. (2020). The effects of high molecular weight hyaluronic acid eye drop application in environmental dry eye stress model mice. International Journal of Molecular Sciences, 21(10), 3516. https://doi.org/10.3390/ijms21103516
Soong, H. K., Chou, W.-L., & Lee, H.-J. (2008). A comparison of vitamin A and cyclosporine A 0.05% eye drops for treatment of dry eye syndrome. American Journal of Ophthalmology, 145(2), 188–196. https://doi.org/10.1016/j.ajo.2007.08.033
Pauloin, T., Dutot, M., Joly, F., Warnet, J.-M., & Rat, P. (2008). In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride. European Journal of Pharmaceutical Sciences, 34(4–5), 263–273. https://doi.org/10.1016/j.ejps.2008.04.006
Köppe, M. K., Hallak, M. K., Stengele, A. L., Khoramnia, R., & Auffarth, G. U. (2024). Evaluation of dry eye treatment with sodium hyaluronate-and dexpanthenol-containing eye drops on ocular surface improvement after cataract surgery. Diagnostics, 14(11), 1097.
Sabur, H., & Acar, M. (2023). Dexpanthenol/sodium hyaluronate eye drops for corneal epithelial healing following corneal cross-linking in patients with keratoconus. International Ophthalmology, 43(10), 3461-3469.
Suárez-Cortés T, Gonzalo A, Arana E, Guillén V, Andollo N. Ophthalmic Formulations for the Treatment of Allergic Conjunctivitis and Their Effect on the Ocular Surface: A Review of Safety and Tolerability Assessments in Clinical Trials. J Clin Med. 2024 Nov 16;13(22):6903. doi: 10.3390/jcm13226903. PMID: 39598046; PMCID: PMC11595245.
Joo, K. S., Chun, Y. S., & Kim, J. C. (2010). Clinical effects of combination therapy using heparin and phospholipid in severe dry eye syndrome. Journal of the Korean Ophthalmological Society, 51(8), 1047–1053. https://doi.org/10.3341/jkos.2010.51.8.1047
Ballesteros-Sánchez, A., De-Hita-Cantalejo, C., Sánchez-González, M. C., Jansone-Langine, Z., Alvarez de Sotomayor, M., Culig, J., & Sánchez-González, J. M. (2023). Perfluorohexyloctane in dry eye disease: A systematic review of its efficacy and safety as a novel therapeutic agent. The Ocular Surface, 30, 254–262. https://doi.org/10.1016/j.jtos.2023.10.001
Tauber, J., Wirta, D. L., Sall, K., Majmudar, P. A., Willen, D., Krösser, S., … SEECASE Study Group. (2021). A randomized clinical study (SEECASE) to assess efficacy, safety, and tolerability of NOV03 for treatment of dry eye disease. Cornea, 40(9), 1132–1140. https://doi.org/10.1097/ICO.0000000000002622
Schmidl, D., Bata, A. M., Szegedi, S., et al. (2020). Influence of perfluorohexyloctane eye drops on tear film thickness in patients with mild to moderate dry eye disease: A randomized controlled clinical trial. Journal of Ocular Pharmacology and Therapeutics, 36(3), 154–161. https://doi.org/10.1089/jop.2020.0081
Aragona, P., Benítez-Del-Castillo, J. M., Coroneo, M. T., Mukherji, S., Tan, J., Vandewalle, E., Vingrys, A., Liu, H., Carlisle-Wilcox, C., Vehige, J., & Simmons, P. A. (2020). Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study. Clinical ophthalmology (Auckland, N.Z.), 14, 2951–2963. https://doi.org/10.2147/OPTH.S256480
Pasquale Aragona, Peter A. Simmons, Hongpeng Wang, Tao Wang; Physicochemical Properties of Hyaluronic Acid–Based Lubricant Eye Drops. Trans. Vis. Sci. Tech. 2019;8(6):2. https://doi.org/10.1167/tvst.8.6.2.
Cyphert, Jaime M., Trempus, Carol S., Garantziotis, Stavros, Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology, International Journal of Cell Biology, 2015, 563818, 8 pages, 2015. https://doi.org/10.1155/2015/563818
Hyaluronic acid in the treatment of dry eye disease Leif Hynnekleiv, Morten Magno, Ragnheidur R. Vernhardsdottir, Emily Moschowits, Kim Alexander Tønseth, Darlene A. Dartt, Jelle Vehof and Tor P. Utheim, Acta Ophthalmologica 2022, p.844-860
Pavel, I. A., Bogdanici, C. M., Donica, V. C., Anton, N., Savu, B., Chiriac, C. P., Pavel, C. D., & Salavastru, S. C. (2023). Computer Vision Syndrome: An Ophthalmic Pathology of the Modern Era. Medicina (Kaunas, Lithuania), 59(2), 412. https://doi.org/10.3390/medicina59020412
